EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Mutational profiling of 103 unresectable pancreatic ductal adenocarcinomas using EUS-guided fine-needle biopsy

Julie Buchberg, Karin de Stricker, Per Pfeiffer, Michael Bau Mortensen, Sönke Detlefsen

Endoscopic Ultrasound · 2024-05 · 13 (3) · 154-164

DOI: 10.1097/eus.0000000000000072 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopic Ultrasound, online erschienen am 03.07.2024. Verfasst von Julie Buchberg und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Odense University Hospital, Odense, Denmark. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objective Pancreatic ductal adenocarcinoma (PDAC) is among the most lethal cancers, with a 5-year survival rate of around 9%. Only 20% are candidates for surgery. Most unresectable patients undergo EUS-guided fine-needle biopsy (EUS-FNB) for diagnosis. Identification of targetable mutations using next-generation sequencing (NGS) is increasingly requested. Data on feasibility of EUS-FNB for NGS and knowledge regarding mutational profile of unresectable PDAC are scarce. We evaluated the “technical yield” of EUS-FNB for NGS in unresectable PDAC: relative fraction of diagnostic EUS-FNBs meeting technical criteria. We also investigated the “molecular yield”: relative fraction of EUS-FNBs included in NGS containing sufficient DNA for detection of at least one mutation. Furthermore, we determined the relative frequency of cancer-associated mutations in unresectable PDAC. Patients and Methods Formalin-fixed and paraffin-embedded EUS-FNBs diagnostic of unresectable PDAC and fulfilling these criteria were included ( n = 105): minimum 3-mm 2 tissue, minimum of 2-mm 2 tumor area, and minimum 20% relative tumor area. NGS was performed using Ion GeneStudio S5 Prime System and Oncomine™ Comprehensive Assay v.3 including 161 cancer-related genes.

Results

Technical yield was 48% (105/219) and molecular yield was 98% (103/105). Most frequently mutated genes were KRAS (89.3%) and TP53 (69.9%), followed by CDKN2A (24.3%), ARID1A (9.7%), SMAD4 (7.8%), TSC2 (7.8%), and CCND3 (6.8%).

Conclusion

EUS-FNB for NGS of unresectable PDAC is feasible. Our technical criteria for NGS, using leftovers in formalin-fixed and paraffin-embedded blocks after routine pathology diagnosis, were met by around half of EUS-FNBs. Almost all EUS-FNBs fulfilling the technical criteria yielded a successful NGS analysis.

Schlagwörter

Stichwörter der Autor:innen

EUSFine-needle biopsyMutational profilingNext-generation sequencingPancreas

Autor:innen und Institutionen

  • Department of Pathology, Odense University Hospital, Odense, Denmark.
  • Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
  • Department of Oncology, Odense University Hospital, Odense, Denmark.
  • Odense Pancreas Center (OPAC), Odense University Hospital, Odense, Denmark.
  • Department of Surgery, Upper GI and HPB Section, Odense University Hospital, Odense, Denmark.

Zitieren

APA

Buchberg, J., de Stricker, K., Pfeiffer, P., Mortensen, M. B., & Detlefsen, S. (2024). Mutational profiling of 103 unresectable pancreatic ductal adenocarcinomas using EUS-guided fine-needle biopsy. Endoscopic Ultrasound, 13(3), 154-164. https://doi.org/10.1097/eus.0000000000000072

Vancouver

Buchberg J, de Stricker K, Pfeiffer P, Mortensen MB, Detlefsen S. Mutational profiling of 103 unresectable pancreatic ductal adenocarcinomas using EUS-guided fine-needle biopsy. Endoscopic Ultrasound. 2024;13(3):154-164. doi:10.1097/eus.0000000000000072

BibTeX
@article{Buchberg2024,
  author = {Buchberg, Julie and de Stricker, Karin and Pfeiffer, Per and Mortensen, Michael Bau and Detlefsen, Sönke},
  title = {Mutational profiling of 103 unresectable pancreatic ductal adenocarcinomas using EUS-guided fine-needle biopsy},
  journal = {Endoscopic Ultrasound},
  year = {2024},
  volume = {13},
  number = {3},
  pages = {154--164},
  doi = {10.1097/eus.0000000000000072}
}
Kostenlos starten →